Recherche
-
Covichem: A biochemical severity risk score of COVID-19 upon hospital admission
(PLoS ONE. vol. 16, n° 5, pp. e0250956, 2021-04-17)Article de revueLibre accès -
Do Different Sutures with Triclosan Have Different Antimicrobial Activities? A Pharmacodynamic Approach
(Antibiotics. vol. 11, n° 9, 2022-09-03)Article de revueLibre accès -
Could JC virus be involved in the onset of multiple system atrophy? A hypothesis
(Parkinsonism & Related Disorders. vol. 109, 2023-04)Article de revue -
Bronchial epithelia from adults and children: SARS-CoV-2 spread via syncytia formation and type III interferon infectivity restriction
(Proceedings of the National Academy of Sciences of the United States of America. vol. 119, n° 28, 2022-07-12)Article de revueLibre accès -
Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients
(Frontiers in Immunology. vol. 13, 2022-03-17)Article de revueLibre accès -
Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004-2022
(Nephrology Dialysis Transplantation, 2023-09-04)Article de revue -
Performance of real-time PCR in suspected haemodialysis catheter-related bloodstream infection: a proof-of-concept study.
(Clinical Kidney Journal. vol. 16, n° 3, pp. 494-500, 2023-03-01)Article de revueLibre accès -
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
(Clinical Microbiology and Infection. vol. 28, n° 7, pp. 1010-1016, 2022-07-01)Article de revueLibre accès -
mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional αβ and γδ T cells in Kidney Transplantation.
(Journal of the American Society of Nephrology. vol. 33, n° 1, 2022-01)Article de revueLibre accès -
Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia
(Journal of Medical Virology. pp. Online ahead of print, 2021-05-03)Article de revueLibre accès